Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rishu Takimoto

Showing results (1-10 of 139) with videos related to

Pageof 14
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 3, 2015
[Disorder of glucose metabolism (hypoglycemia, hyperglycemia)]Rishu Takimoto
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 28, 2004
[Tumor suppressor gene p53 and molecular targeting therapy]Rishu Takimoto, Yoshiro Niitsu
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 31, 2004
[Targeting molecular mechanisms for cancer therapy]Rishu Takimoto, Yoshiro Niitsu
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|April 1, 2004
[Iron metabolism in iron deficiency anemia and anemia of chronic disease]Yoshiro Niitsu, Jyunji Kato, Rishu Takimoto
Molecular and Cellular Biology|May 25, 2002
BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targetsTimothy K MacLachlan, Rishu Takimoto, Wafik S El-Deiry
Molecular and Cellular Biology|March 4, 2003
Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 bindingWenge Wang, Rishu Takimoto, Farzan Rastinejad, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 16, 2010
[Therapeutic results in patients with biphenotypic acute leukemia at Sapporo Medical University Hospital]Kazuyuki Murase, Satoshi Iyama, Tsutomu Sato, et al.
Anticancer Research|July 27, 2022
Efficacy of Adjuvant Immune-cell Therapy Combined With Systemic Therapy for Solid TumorsRishu Takimoto, Takashi Kamigaki, Sachiko Okada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 27, 2025
[A Case of Remarkable Immune-Cell Therapy Efficacy in a Patient with Renal Pelvic Cancer Refractory to Immune Checkpoint Inhibitors and Chemotherapy]Rishu Takimoto, Takashi Kamigaki, Sachiko Okada, et al.
Anticancer Research|July 20, 2021
Prognostic Factors for Advanced/Recurrent Breast Cancer Treated With Immune-cell TherapyRishu Takimoto, Takashi Kamigaki, Sachiko Okada, et al.
Pageof 14

Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 3, 2015
[Disorder of glucose metabolism (hypoglycemia, hyperglycemia)]Rishu Takimoto
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 28, 2004
[Tumor suppressor gene p53 and molecular targeting therapy]Rishu Takimoto, Yoshiro Niitsu
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 31, 2004
[Targeting molecular mechanisms for cancer therapy]Rishu Takimoto, Yoshiro Niitsu
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|April 1, 2004
[Iron metabolism in iron deficiency anemia and anemia of chronic disease]Yoshiro Niitsu, Jyunji Kato, Rishu Takimoto
Molecular and Cellular Biology|May 25, 2002
BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targetsTimothy K MacLachlan, Rishu Takimoto, Wafik S El-Deiry
Molecular and Cellular Biology|March 4, 2003
Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 bindingWenge Wang, Rishu Takimoto, Farzan Rastinejad, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 16, 2010
[Therapeutic results in patients with biphenotypic acute leukemia at Sapporo Medical University Hospital]Kazuyuki Murase, Satoshi Iyama, Tsutomu Sato, et al.
Anticancer Research|July 27, 2022
Efficacy of Adjuvant Immune-cell Therapy Combined With Systemic Therapy for Solid TumorsRishu Takimoto, Takashi Kamigaki, Sachiko Okada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 27, 2025
[A Case of Remarkable Immune-Cell Therapy Efficacy in a Patient with Renal Pelvic Cancer Refractory to Immune Checkpoint Inhibitors and Chemotherapy]Rishu Takimoto, Takashi Kamigaki, Sachiko Okada, et al.
Anticancer Research|July 20, 2021
Prognostic Factors for Advanced/Recurrent Breast Cancer Treated With Immune-cell TherapyRishu Takimoto, Takashi Kamigaki, Sachiko Okada, et al.
Pageof 14